Browsing Tag

Atossa Therapeutics

Atossa Therapeutics Begins Enrollment of Phase 2 Clinical Study of Oral Endoxifen in…

Eli Pacheco Dec 23, 2021 0

SEATTLE, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of…

Health

Atossa Therapeutics Completes Pre-IND Meeting with U.S. Food & Drug…

Eli Pacheco Dec 6, 2021 0

SEATTLE, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in…

Health

Registration Is Now Open For The Tribe Public Webinar Event On November 30, 2021 “A…

Eli Pacheco Nov 24, 2021 0

SEATTLE, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of…

Health

Atossa Therapeutics Begins Enrollment in Clinical Study of AT-H201 in Australia

Eli Pacheco Sep 30, 2021 0

SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in…

Health

Atossa Therapeutics Receives Regulatory Approval To Open Clinical Study of AT-H201 in…

Eli Pacheco Jul 7, 2021 0

Nebulized formulation being developed to improve lung function in both active-disease COVID-19 patients and “Long Haul” patients with post-infection pulmonary disease SEATTLE, July 07,…

Health

Atossa Therapeutics Receives Approval from Swedish Regulators to Initiate Phase 2…

Eli Pacheco Jun 11, 2021 0

SEATTLE, June 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in…

Newer Posts